DK0652751T3 - Injektionspræparat og injektions-kit indeholdende omeprazol og dens analoger - Google Patents

Injektionspræparat og injektions-kit indeholdende omeprazol og dens analoger

Info

Publication number
DK0652751T3
DK0652751T3 DK93916182.4T DK93916182T DK0652751T3 DK 0652751 T3 DK0652751 T3 DK 0652751T3 DK 93916182 T DK93916182 T DK 93916182T DK 0652751 T3 DK0652751 T3 DK 0652751T3
Authority
DK
Denmark
Prior art keywords
injection
pct
analogues
kit containing
containing omeprazole
Prior art date
Application number
DK93916182.4T
Other languages
English (en)
Inventor
Shigeo Nakanishi
Tetsuo Tominaga
Takashi Higo
Toshiyuki Shibata
Iwao Yamanaka
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=16437061&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0652751(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Ab filed Critical Astra Ab
Application granted granted Critical
Publication of DK0652751T3 publication Critical patent/DK0652751T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Dental Preparations (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK93916182.4T 1992-07-28 1993-07-15 Injektionspræparat og injektions-kit indeholdende omeprazol og dens analoger DK0652751T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20120392 1992-07-28

Publications (1)

Publication Number Publication Date
DK0652751T3 true DK0652751T3 (da) 1996-11-18

Family

ID=16437061

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93916182.4T DK0652751T3 (da) 1992-07-28 1993-07-15 Injektionspræparat og injektions-kit indeholdende omeprazol og dens analoger

Country Status (20)

Country Link
US (1) US5589491A (da)
EP (1) EP0652751B1 (da)
KR (1) KR100258423B1 (da)
AT (1) ATE144421T1 (da)
AU (1) AU674015B2 (da)
CA (1) CA2140347C (da)
CZ (1) CZ284249B6 (da)
DE (1) DE69305642T2 (da)
DK (1) DK0652751T3 (da)
ES (1) ES2093445T3 (da)
FI (1) FI113338B (da)
GR (1) GR3021937T3 (da)
HK (1) HK52397A (da)
HU (1) HU226778B1 (da)
NO (1) NO304098B1 (da)
NZ (1) NZ254237A (da)
RU (1) RU2126252C1 (da)
SG (1) SG52479A1 (da)
SK (1) SK279554B6 (da)
WO (1) WO1994002141A1 (da)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4324014C2 (de) * 1993-07-17 1995-06-08 Byk Gulden Lomberg Chem Fab Verfahren zur Herstellung einer in Wasser rekonstituierbaren Zubereitung
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6174548B1 (en) 1998-08-28 2001-01-16 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6096340A (en) * 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6733778B1 (en) 1999-08-27 2004-05-11 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6780880B1 (en) 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6316020B1 (en) * 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
SE9903831D0 (sv) * 1999-10-22 1999-10-22 Astra Ab Formulation of substituted benzimidazoles
WO2002015908A1 (fr) * 2000-08-18 2002-02-28 Takeda Chemical Industries, Ltd. Injections
WO2002026210A2 (en) * 2000-09-29 2002-04-04 Geneva Pharmaceuticals Inc. Proton pump inhibitor formulation
MY137726A (en) 2000-11-22 2009-03-31 Nycomed Gmbh Freeze-dried pantoprazole preparation and pantoprazole injection
US20020192299A1 (en) * 2000-12-28 2002-12-19 Rajneesh Taneja Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination
KR100467100B1 (ko) * 2002-03-20 2005-01-24 일양약품주식회사 2-[(4-메톡시-3-메틸)-2-피리디닐]메틸설피닐-5-(1Ｈ-피롤-1-릴)-1Ｈ-벤즈이미다졸 또는 이의 Ｎа염을 함유하는주사제의 제조방법
US20030228363A1 (en) * 2002-06-07 2003-12-11 Patel Mahendra R. Stabilized pharmaceutical compositons containing benzimidazole compounds
US20040081671A1 (en) * 2002-07-03 2004-04-29 Rajneesh Taneja Liquid dosage forms of non-enterically coated acid-labile drugs
US20040082618A1 (en) * 2002-07-03 2004-04-29 Rajneesh Taneja Liquid dosage forms of acid labile drugs
US20040006109A1 (en) * 2002-07-03 2004-01-08 Rajneesh Taneja Liquid dosage forms of non-enterically coated acid-labile drugs
US20070243251A1 (en) * 2002-12-20 2007-10-18 Rajneesh Taneja Dosage Forms Containing A PPI, NSAID, and Buffer
US20040121004A1 (en) * 2002-12-20 2004-06-24 Rajneesh Taneja Dosage forms containing a PPI, NSAID, and buffer
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
AR045258A1 (es) * 2003-08-21 2005-10-19 Altana Pharma Ag Un producto farmaceutico para inyeccion
BRPI0416027A (pt) 2003-11-05 2007-01-02 Lyka Labs Ltd sistema de entrega de drogas para inibidores de bomba de prótons e processo resultante
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20070026071A1 (en) * 2005-07-28 2007-02-01 Qpharma, Llc Magnesium salt proton pump inhibitor dosage forms
WO2007091276A2 (en) * 2006-02-10 2007-08-16 Rajasthan Antibiotic Limited Novel crystal form of omeprazol sodium
CN104288175A (zh) * 2014-09-17 2015-01-21 大生祥(武汉）中医投资管理有限公司 一种新的苯并咪唑类异构体制剂及其制备方法
CN105919953A (zh) * 2016-06-27 2016-09-07 峨眉山通惠制药有限公司 一种注射用奥美拉唑钠组合物及其制作工艺
GB2585628A (en) * 2019-05-08 2021-01-20 Alkaloid Ad Pharmaceutical formulation
CN112807282A (zh) * 2021-01-13 2021-05-18 海南葫芦娃药业集团股份有限公司 一种奥美拉唑钠冻干粉针剂及其制备方法
WO2024075017A1 (en) 2022-10-04 2024-04-11 Zabirnyk Arsenii Inhibition of aortic valve calcification

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE416649B (sv) * 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4359465A (en) * 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
US4472409A (en) * 1981-11-05 1984-09-18 Byk Gulden Lomberg Chemische Fabrik Gesellschaft Mit Beschrankter Haftung 2-Pyridylmethyl thio(sulfinyl)benzimidazoles with gastric acid secretion inhibiting effects
SE8300736D0 (sv) * 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
SE8301182D0 (sv) * 1983-03-04 1983-03-04 Haessle Ab Novel compounds
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
DK399389A (da) * 1988-08-18 1990-02-19 Takeda Chemical Industries Ltd Injicerbare oploesninger
DK0382489T3 (da) * 1989-02-10 1995-01-16 Takeda Chemical Industries Ltd Monoklonalt anti-humant papillomvirusantistof, hybridomcelle, der producerer dette, samt fremgangsmåde til fremstilling deraf
US5049674A (en) * 1989-12-20 1991-09-17 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles

Also Published As

Publication number Publication date
GR3021937T3 (en) 1997-03-31
CA2140347A1 (en) 1994-02-03
RU2126252C1 (ru) 1999-02-20
SG52479A1 (en) 1998-09-28
KR950702419A (ko) 1995-07-29
SK279554B6 (sk) 1998-12-02
FI950379A0 (fi) 1995-01-27
AU674015B2 (en) 1996-12-05
EP0652751B1 (en) 1996-10-23
DE69305642D1 (de) 1996-11-28
FI950379A (fi) 1995-01-27
ES2093445T3 (es) 1996-12-16
ATE144421T1 (de) 1996-11-15
CA2140347C (en) 2001-03-27
US5589491A (en) 1996-12-31
WO1994002141A1 (en) 1994-02-03
NZ254237A (en) 1995-12-21
AU4583893A (en) 1994-02-14
HUT71900A (en) 1996-02-28
DE69305642T2 (de) 1997-02-27
CZ284249B6 (cs) 1998-10-14
NO950178D0 (no) 1995-01-17
HK52397A (en) 1997-05-02
KR100258423B1 (ko) 2000-07-01
EP0652751A1 (en) 1995-05-17
NO950178L (no) 1995-01-17
HU9500245D0 (en) 1995-03-28
SK10095A3 (en) 1995-07-11
NO304098B1 (no) 1998-10-26
FI113338B (fi) 2004-04-15
CZ21795A3 (en) 1995-10-18
HU226778B1 (en) 2009-10-28

Similar Documents

Publication Publication Date Title
DK0652751T3 (da) Injektionspræparat og injektions-kit indeholdende omeprazol og dens analoger
RU95104936A (ru) Препарат для инъекций и набор для инъекций, содержащие омепразол и его аналоги
DK0697019T3 (da) Risperidon pamoater
TW200407287A (en) A sulfonated amine acid derivative and the metalloproteinase inhibitor containing it (I)
NO881974L (no) Varmeherdende silikonsammensetninger innbefattende fumarsure salter som herdekontrolltilsetningsstoff og bruk av disse.
ATE122567T1 (de) Insulinzubereitungen, die nikotinsäure oder nikotinamid enthalten.
ATE298334T1 (de) Kristalle von lansoprazole
TR199700844T1 (xx) Pirazolil-Benzoil T�revleri.
MY105136A (en) Optically active pyridonecarboxylic acid derivatives.
DE68919436D1 (de) Stabilisierter, aus Fäden bestehender Vliesstoff.
DE69201838D1 (de) Entfernung von gelösten Chelaten aus wässrigen Lösungen.
MY106474A (en) Guanidine derivatives.
MY101864A (en) Barbituric acid derivatives
DE59005355D1 (de) Dialysier- und Spüllösung zur intraperitonealen Verarbreichung.
ATE75399T1 (de) Therapeutikum zur behandlung von magengeschwueren.
NO941084L (no) Neuroleptiske 2-substituerte perhydro-1-H-pyrido[1,2-aÅpyraziner
WO1995018122A3 (en) Heteroarylpyrroles
WO2000018361A3 (en) Method of treating hair loss using sulfonamides
TH69761B (th) ผลึกสารประกอบเบนซิมิแดซอล
KR880013453A (ko) 제초제 조성물
SU1631969A1 (ru) Дигидрохлорид-5-(2-окси-3,3-диметилбутил)-1-метил-4,5,6,7-тетрагидротриазо ло[4,5-c]пиридина, обладающий антигипертензивным и гипотензивным действием
SU1573831A1 (ru) Соли n-фосфонометилглицина, обладающие гербицидной активностью
SU1499898A1 (ru) СОЛИ 9-ДИАЛКИЛАМИНОЭТИЛ-2-МЕТИЛ-3-ТЕНОИЛИМИДАЗО[1,2-а]БЕНЗИМИДАЗОЛА, ОБЛАДАЮЩИЕ АНТИРАДИОМИМЕТИЧЕСКИМ ДЕЙСТВИЕМ